Diagnosis rests on your age, changes in your menstrual cycle pattern, and a compatible pattern of symptoms, not on a lab value.
The international staging system used to describe reproductive aging is built entirely on menstrual bleeding criteria: entering the early transition is defined by a persistent difference of 7 or more days in the length of consecutive cycles, and the late transition by a gap of 60 or more days without a period. This staging system is applied the same way regardless of age, ethnicity, body size, or lifestyle, though it cannot be used in women who cannot be staged by bleeding alone, such as those with PCOS or after a hysterectomy. The whole 'chaotic' window this describes typically spans several years, not weeks or months.
There is little dispute about the staging system itself; the practical tension is that bleeding-based criteria work well for a woman with a uterus and regular natural cycles, but cannot be applied directly to women on hormonal contraception, after hysterectomy or ablation, or with conditions like PCOS that also disrupt cycles.
What the research shows, and which source each finding rests on
STRAW+10 (2011 workshop, published 2012) is the international standard for staging reproductive aging, anchored to the final menstrual period, defining the continuum from the reproductive years through the early and late menopausal transition to postmenopause.
STRAW+10 staging is built on menstrual bleeding criteria: entry to the early transition is defined by a persistent difference of 7 or more days in consecutive cycle length; the late transition is defined by an interval of amenorrhea of 60 or more days. Elevated FSH is only a supportive criterion for the late transition, with a caution that values are assay-dependent.
STRAW+10 is meant to be applied regardless of a woman's age, ethnicity, body size, or lifestyle, but special populations (PCOS, primary ovarian insufficiency, hysterectomy, endometrial ablation, chronic illness, chemotherapy) cannot be staged by bleeding criteria alone.
The late transition is expected to last approximately 1-3 years, and hormonal stabilization after the final period takes about 2 more years - the full chaotic window spans years, not months.
Where the real disagreement is
Each position is shown with its own sources. A position listed here is not necessarily the accepted view.
The system works well but has real blind spots
the staging system's own authors, and clinicians managing special populations
STRAW+10 explicitly states it cannot stage women with PCOS, primary ovarian insufficiency, hysterectomy, endometrial ablation, chronic illness, or chemotherapy by bleeding criteria alone, meaning a meaningful group of women need a different, less standardized diagnostic conversation.
What would settle it: Validated staging approaches specifically for the special populations the current bleeding-based system cannot classify.
What is really going on here
- Does that guideline apply to someone my age, or was it built around a different life stage?
- Am I in one of the special populations, like PCOS, hysterectomy, or hormonal contraception, where bleeding-based staging can't be used directly?
Questions for your doctor
- Based on my cycle history and symptoms, where do you think I am in this transition?
- Have you ruled out other explanations, like thyroid disease, iron deficiency, or pregnancy?
- Since I can't be staged by bleeding pattern, what are you using instead?
Questions with no answer yet
For the special populations the bleeding-based staging system explicitly cannot classify, such as women with PCOS or after hysterectomy, is there any diagnostic approach that has actually been validated, or is this simply unaddressed?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: The staging system's own authors state plainly that these populations cannot be staged by bleeding criteria alone, but no validated alternative staging approach for them has been published. Current practice in these cases is described as treating the clinical picture pragmatically rather than following a tested protocol.
What would test it: Validated staging approaches specifically for the special populations the current bleeding-based system cannot classify.
Does the retrospective nature of the menopause definition, only knowable 12 months after the fact, create real, measurable diagnostic delays, or is this mainly a definitional curiosity that does not affect care in practice?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: The definitional structure is described in the source material as a trap, since certainty is only available after the fact, but whether this actually delays treatment decisions in measurable ways, as opposed to being a technical detail clinicians already work around, has not been studied directly.
What would test it: A study measuring time from symptom onset to treatment initiation, comparing cases where retrospective definitional uncertainty was and was not a documented factor in clinical decision-making.
Sources
- 1.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10 (STRAW+10). Menopause 2012;19(4):387-95. · Systematic review or guideline
- 2.NICE. Menopause: identification and management. NICE guideline NG23 (2015, updated November 2024), section 1.2.Systematic review or guideline
The letter grades the type of study behind a claim, not the answer itself.
This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.
You are not imagining it
In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.
Start Free MappingRelated questions
- Is there a test for perimenopause?
- Why did my doctor say my hormones are normal, when I feel terrible?
- How many doctors do women typically see before someone finally tells them it's perimenopause?
- I read that most women with menopause symptoms never seek help - is that really true?
- What about AMH testing - can that tell me when I'll hit menopause?
- Why do so many doctors seem to know so little about menopause?
- Back to topic: Spotting perimenopause, hormone testing and the care gap